Product Introduction
Retatrutide is a triple receptor agonist peptide (GIP/GLP-1/Glucagon) widely studied in metabolic and obesity research.
This product is supplied as a lyophilized sterile powder (5mg/vial) intended strictly for laboratory and scientific research applications only.
Key Product Specifications
|
Parameter |
Specification |
|
Product Name |
Retatrutide 5mg Vial |
|
CAS Number |
2381089-83-2 |
|
Molecular Formula |
C221H342N46O68 |
|
Molecular Weight |
4731.33 g/mol |
|
Purity |
99% (HPLC verified batch dependent up to 99.09%) |
|
Form |
Lyophilized powder |
|
Dosage Options |
2mg / 5mg / 10mg / 15mg / 20mg / 30mg |
|
MOQ |
10 vials / box |
|
Shelf Life |
2 years (proper storage condition) |
|
Storage |
2–8°C, dry, light-protected |
Structural & Mechanism
Retatrutide is engineered to activate three metabolic pathways:
- GLP-1 receptor (appetite suppression & glucose control)
- GIP receptor (insulin sensitivity enhancement)
- Glucagon receptor (energy expenditure & fat oxidation)
Quality Control System
Each batch undergoes multi-step analytical validation:
Analytical Testing Methods
- HPLC (purity & impurity profiling)
- Mass Spectrometry (molecular confirmation)
- Karl Fischer (moisture content)
- Endotoxin testing (biological safety)
- Lon & residual solvent analysis
Batch Test Results
|
Test Item |
Specification |
Result |
|
Appearance |
White or almost white powder |
Conform |
|
Solubility |
Soluble in water |
Conform |
|
Water Content |
≤ 8.0% |
4.00% |
|
Sodium Ion |
≤ 5.0% |
1.33% |
|
Trifluoroacetic Acid |
≤ 0.5% |
0.19% |
|
Acetic Acid |
≤ 0.5% |
0.02% |
|
Peptide Purity (HPLC) |
≥ 98.0% |
99.09% |
|
Total Impurities |
≤ 2.0% |
0.92% |
|
Largest Single Impurity |
≤ 1.0% |
0.44% |
|
Endotoxins |
≤ 10 EU/mg |
Conform |
|
Assay |
≥ 90.0% |
94.00% |
Manufacturing Capability
Produced under GMP-controlled environment by:
|
Facility size |
26,700 m² |
|
Reactor capacity |
200L–5000L |
|
Monthly output |
Up to 10 tons |
|
Certification |
ISO 9001 2015 + GMP compliance |
|
Technical team |
20+ years peptide synthesis experience |
Application Areas
Retatrutide is widely used in:
Obesity mechanism research
Glucose metabolism studies
Insulin resistance pathway analysis
Energy expenditure research
Incretin hormone signaling studies
Fat oxidation and lipid metabolism research
Packaging & Shipping Details
To ensure product stability and integrity:
Primary packaging: sterile borosilicate glass vial
Sealing: rubber stopper + aluminum crimp seal
Secondary packaging: shock-resistant insulated box
Optional: cold-chain (2–8°C) shipping
Labeling: batch number + COA reference code
Documentation: COA + MSDS + export invoice
OEM / ODM Customization Options
We support flexible customization:
Product
Peptide sequence modification
Purity grade (98%–99.5%)
Dosage strength (2mg–50mg)
Formulation
Lyophilized powder
Injectable solution development (research use)
Packaging
Single vial / multi-vial box
Private label printing
Custom branding design
Regulatory labeling (RUO / API / intermediate)
Comparison With Other Incretin Agents
|
Product |
Receptor Coverage |
|
Semaglutide |
GLP-1 |
|
Tirzepatide |
GLP-1 + GIP |
|
Retatrutide |
GLP-1 + GIP + GCGR |
FAQ
Q: What is the minimum order quantity (MOQ)?
A: Standard MOQ is 10 vials per box for bulk supply.
Q: Can COA and HPLC reports be provided?
A: Yes, full COA with HPLC and MS data is available for every batch.
Q: What purity level do you guarantee?
A: Typical purity is ≥98%, with batches reaching up to 99.09% HPLC verified.
Q: Do you support OEM private labeling?
A: Yes, we offer full OEM/ODM services including packaging and branding.
Q: Is this product suitable for human use?
A: No, it is strictly for laboratory research use only (RUO).
Hot Tags: retatrutide 5mg vial, China retatrutide 5mg vial manufacturers, suppliers, factory
